AAAAAA
Results: 26-50/75
Authors:
Yoo, SJ
Kahan, BD
Citation: Sj. Yoo et Bd. Kahan, Combination treatment with sirolimus and ciclosporin in clinical renal transplantation: A comprehensive review, DRUGS TODAY, 37(6), 2001, pp. 385-400
Authors:
Behbod, F
Erwin-Cohen, RA
Wang, ME
Trawick, BW
Qu, X
Verani, R
Kahan, BD
Stepkowski, SM
Kirken, RA
Citation: F. Behbod et al., Concomitant inhibition of janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts, J IMMUNOL, 166(6), 2001, pp. 3724-3732
Authors:
Kahan, BD
Kramer, WG
Citation: Bd. Kahan et Wg. Kramer, Median effect analysis of efficacy versus adverse effects of immunosuppressants, CLIN PHARM, 70(1), 2001, pp. 74-81
Authors:
Kovarik, JM
Kahan, BD
Kaplan, B
Lorber, M
Winkler, M
Rouilly, M
Gerbeau, C
Cambon, N
Boger, R
Rordorf, C
Citation: Jm. Kovarik et al., Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: Pharmacokinetics, exposure-responserelationships, and influence on cyclosporine, CLIN PHARM, 69(1), 2001, pp. 48-56
Authors:
Kahan, BD
Welsh, M
Urbauer, DL
Mosheim, MB
Beusterien, KM
Wood, MR
Schoenberg, LP
Dicesare, J
Katz, SM
Van Buren, CT
Citation: Bd. Kahan et al., Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs, J AM S NEPH, 11(6), 2000, pp. 1122-1131
Authors:
Katz, SM
Bennett, F
Stecker, K
Clark, JH
Phan, T
Wang, M
Kahan, BD
Stepkowski, SM
Citation: Sm. Katz et al., ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and function, CELL TRANSP, 9(6), 2000, pp. 817-828
Authors:
Portman, RJ
Meier-Kriesche, HU
Swinford, R
Brannan, P
Kahan, BD
Citation: Rj. Portman et al., Reduced variability of Neoral pharmacokinetic studies in pediatric renal transplantation, PED NEPHROL, 15(1-2), 2000, pp. 2-6
Authors:
Kahan, BD
Napoli, KL
Kelly, PA
Podbielski, J
Hussein, I
Urbauer, DL
Katz, SH
Van Buren, CT
Citation: Bd. Kahan et al., Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity, CLIN TRANSP, 14(2), 2000, pp. 97-109
Authors:
Hong, JC
Kahan, BD
Citation: Jc. Hong et Bd. Kahan, Immunosuppressive agents in organ transplantation: Past, present, and future, SEM NEPHROL, 20(2), 2000, pp. 108-125
Authors:
Kahan, BD
Citation: Bd. Kahan, Sirolimus vs azathioprine - Reply, LANCET, 356(9243), 2000, pp. 1768-1769
Authors:
Kahan, BD
Citation: Bd. Kahan, Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study, LANCET, 356(9225), 2000, pp. 194-202
Authors:
Katz, SM
Hong, JC
Kahan, BD
Citation: Sm. Katz et al., New immunosuppressive agents, TRANSPLAN P, 32(3), 2000, pp. 620-621
Authors:
Yuzawa, K
Stephkowski, SM
Wang, M
Kahan, BD
Citation: K. Yuzawa et al., FTY720 blocks allograft rejection by homing of lymphocytes in vivo, TRANSPLAN P, 32(2), 2000, pp. 269-269
Authors:
Okamoto, M
Stepkowski, SM
Wang, M
Kahan, BD
Citation: M. Okamoto et al., Use of allochimeric proteins to mitigate graft-versus-host and host-versus-graft immune responses to rat small bowel allografts, TRANSPLANT, 70(7), 2000, pp. 1060-1067
Authors:
Hong, JC
Kahan, BD
Citation: Jc. Hong et Bd. Kahan, Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: Risk factors, incidence, progression, and management, TRANSPLANT, 69(10), 2000, pp. 2085-2090
Authors:
Kilic, M
Kahan, BD
Citation: M. Kilic et Bd. Kahan, New trends in immunosuppression, DRUGS TODAY, 36(6), 2000, pp. 395-410
Authors:
Holt, DW
Johnston, A
Kahan, BD
Morris, RG
Oellerich, M
Shaw, LM
Citation: Dw. Holt et al., New approaches to cyclosporine monitoring raise further concerns about analytical techniques, CLIN CHEM, 46(6), 2000, pp. 872-874
Authors:
Davis, DL
Murthy, JN
Napoli, KL
Kahan, BD
Gallant-Haidner, H
Yatscoff, RW
Soldin, SJ
Citation: Dl. Davis et al., Comparison of steady-state trough sirolimus samples by HPLC and a radioreceptor assay, CLIN BIOCH, 33(1), 2000, pp. 31-36
Authors:
Meier-Kriesche, HU
Bonilla-Felix, MA
Ferris, ME
Swinford, R
Kahan, BD
Brannan, P
Portman, RJ
Citation: Hu. Meier-kriesche et al., A limited sampling strategy for the estimation of Neoral AUCs in pediatricpatients, PED NEPHROL, 13(9), 1999, pp. 742-747
Authors:
Kelly, PA
Wang, H
Napoli, KL
Kahan, BD
Strobel, HW
Citation: Pa. Kelly et al., Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4, EUR J DRUG, 24(4), 1999, pp. 321-328
Authors:
Monaco, AP
Burke, JF
Ferguson, RM
Halloran, PF
Kahan, BD
Light, JA
Matas, AJ
Solez, K
Citation: Ap. Monaco et al., Current thinking on chronic renal allograft rejection: Issues, concerns, and recommendations from a 1997 roundtable discussion, AM J KIDNEY, 33(1), 1999, pp. 150-160
Authors:
Kaplan, B
Meier-Kriesche, HU
Napoli, KL
Kahan, BD
Citation: B. Kaplan et al., Correlation between pretransplantation test dose cyclosporine pharmacokinetic profiles and posttransplantation sirolimus blood levels in renal transplant recipients, THER DRUG M, 21(1), 1999, pp. 44-49
Authors:
Kelly, PA
Napoli, K
Kahan, BD
Citation: Pa. Kelly et al., Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipients, BIOPHARM DR, 20(5), 1999, pp. 249-253
Authors:
Tian, L
Wang, M
Yu, J
Kahan, BD
Stepkowski, SM
Citation: L. Tian et al., Nucleotide sequences of three distinct complementary DNA clones encoding rat class II major histocompatibility complex RT1.D beta-chain proteins, IMMUNOGENET, 49(7-8), 1999, pp. 735-737
Authors:
Akioka, K
Kirkin, R
Wang, M
Tian, L
Yu, J
Stepkowski, SM
Kahan, BD
Citation: K. Akioka et al., Reduced expression of NF-AT and NF-kappa B transcription factors in tolerant recipients treated with tolerogenic allochimeric donor/recipient class IMHC protein, TRANSPLAN P, 31(7), 1999, pp. 2745-2746